BR0101439A - Derivados de eritromicina a - Google Patents

Derivados de eritromicina a

Info

Publication number
BR0101439A
BR0101439A BR0101439-0A BR0101439A BR0101439A BR 0101439 A BR0101439 A BR 0101439A BR 0101439 A BR0101439 A BR 0101439A BR 0101439 A BR0101439 A BR 0101439A
Authority
BR
Brazil
Prior art keywords
erythromycin derivatives
erythromycin
derivatives
tautomers
prodrugs
Prior art date
Application number
BR0101439-0A
Other languages
English (en)
Inventor
Takushi Kaneko
William Thomas Mcmillen
Yong-Jin Wu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0101439A publication Critical patent/BR0101439A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Patente de Invenção: "DERIVADOS DE ERITROMICINA A". Apresente invenção refere-se a compostos de fórmula e a seus sais,pró-drogas, tautómeros, e solvatos farmaceuticamente aceitáveis,em que R^ 1^, R^ 2^, R^ 3^, R^ 10^ B e X^ 1^ sejam definidos talcomo se descrevem neste documento.
BR0101439-0A 2000-04-10 2001-04-11 Derivados de eritromicina a BR0101439A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19604500P 2000-04-10 2000-04-10

Publications (1)

Publication Number Publication Date
BR0101439A true BR0101439A (pt) 2001-12-04

Family

ID=22723913

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0101439-0A BR0101439A (pt) 2000-04-10 2001-04-11 Derivados de eritromicina a

Country Status (6)

Country Link
US (1) US20030100742A1 (pt)
EP (1) EP1146051A3 (pt)
JP (1) JP2001348397A (pt)
BR (1) BR0101439A (pt)
CA (1) CA2343344A1 (pt)
MX (1) MXPA01003647A (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200100613A (et) 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
PL370714A1 (en) 2001-12-05 2005-05-30 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
AU2003234650A1 (en) * 2002-05-31 2003-12-19 Janssen Pharmaceutica N.V. 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents
WO2004026889A1 (en) * 2002-09-20 2004-04-01 The University Of Manchester Antibiotic derivatives of erythromycin
AP2007004026A0 (en) 2004-12-21 2007-06-30 Pfizer Prod Inc Macrolides
CN106928294A (zh) * 2017-03-22 2017-07-07 上海启雁实业有限公司 制备酮内酯大环内酯类抗生素的方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521402D0 (en) * 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
CA2096969C (en) * 1990-11-28 2000-11-21 Masato Kashimura 6-0-methylerythromycin a derivatives
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
US5631355A (en) * 1992-04-22 1997-05-20 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide a derivatives
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
FR2745290B1 (fr) * 1996-02-28 1998-04-03 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0918783A1 (en) * 1996-05-07 1999-06-02 Abbott Laboratories 6-o-substituted erythromycins and method for making them
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
JP2000511063A (ja) * 1996-07-05 2000-08-29 バイオティカ テクノロジー リミティド ポリケチド類及びそれらの合成
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
CZ180799A3 (cs) * 1996-11-27 1999-09-15 Taisho Pharmaceutical Co., Ltd. Deriváty erythromycinu A
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
PA8461401A1 (es) * 1997-10-29 2000-05-24 Pfizer Prod Inc Derivados de eritromicina triciclicos
DE69919769T2 (de) * 1998-03-03 2005-01-27 Pfizer Products Inc., Groton 3,6-Ketal-Makrolidantibiotika
US5972898A (en) * 1998-03-27 1999-10-26 Abbott Laboratories 3',3-N-bis-substituted macrolide LHRH antagonists
US5955440A (en) * 1998-03-27 1999-09-21 Abbott Laboratories Macrolide LHRH antagonists
WO1999062920A1 (en) * 1998-06-03 1999-12-09 Pfizer Products Inc. Tricyclic 3-keto derivatives of 6-o-methylerythromycin
US6020521A (en) * 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
US6387885B1 (en) * 1998-08-26 2002-05-14 Abbott Laboratories 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
KR20010083944A (ko) * 1998-11-03 2001-09-03 실버스타인 아써 에이. 신규 마크롤라이드 항생물질
JP2003501439A (ja) * 1999-06-07 2003-01-14 アボット・ラボラトリーズ ６−ｏ−カルバメートケトライド誘導体

Also Published As

Publication number Publication date
MXPA01003647A (es) 2005-06-30
JP2001348397A (ja) 2001-12-18
EP1146051A2 (en) 2001-10-17
CA2343344A1 (en) 2001-10-10
US20030100742A1 (en) 2003-05-29
EP1146051A3 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
NL350075I2 (pt)
MXPA03005464A (es) Agentes antivirales.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
MY139243A (en) Prodrugs of piperazine and substituted piperidine antiviral agents.
BR0307267A (pt) Compostos heterocìclicos, ativos como inibidores de beta-lacta-mases
BR0309669A (pt) Compostos de anilina de pirrolo-triazina úteis como inibidores de cinase
YU46303A (sh) 6-0-karbamoil ketolidni derivati eritromicina korisni kao antibakterijska sredstva
BR0112395A (pt) Derivados de benzotiazol
EP1248612A4 (en) NEW SUBSTANCES AND COMPOUNDS AS PROTEASE INHIBITORS
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
DE60107449D1 (de) Substituierte aminopropoxyarylderivate als lxr agonisten
BR0109836A (pt) Processo de sìntese de perindopril e de seus sais farmaceuticamente aceitáveis
DE60121461D1 (de) Kondensierte pyridoindolderivate
BR0010938A (pt) Derivados da 13-metil eritromicina
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
IT1312115B1 (it) Composti amorfi e relative composizioni farmaceutiche
BR9905089A (pt) Derivados macrolìdeos
BR0100982A (pt) Processo para a preparação de derivados deresorcinol
BR0101439A (pt) Derivados de eritromicina a
DE60112960D1 (de) Kondensierte pyridoindolderivate
MXPA05009282A (es) Derivados de anilina sustituidos.
BR0015333A (pt) Derivados de isoxazol como inibidores de fosfodiesterase vii
BR0108500A (pt) Arilpiperazinas e arilpiperidinas e seu uso como agentes inibidores de metaloproteinase
DE60216948D1 (en) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009.